Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Why we cannot afford to let the healthtech boom lose pace post-COVID-19
Rupert Spiegelberg, CEO of Doctorlink, explains why we cannot accord to let the healthtech boom lose pace in a post-COVID-19 reality.
Russia approves COVID-19 vaccine before completing trials
Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.
How employee ideas can play a role in the green recovery from COVID-19
Chris Sheen, COO for Sideways 6, explores how employee innovation can play a role in the green recovery from COVID-19.
Covid-19: UK falls into recession for the first time in 11 years
The COVID-19 outbreak caused the UK to enter the deepest recession since records began, with GDP falling a staggering 20.4%.
The science behind the South Korea COVID-19 strategy
Jongeun You explains how the South Korea COVID-19 strategy flattened the curve, without destroying the economy.
Single-cell genomics: Clinical strategies for COVID-19
Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.
How COVID-19 is driving AI adoption across the healthcare industry
Vincent Grasso, Global Healthcare & Life Sciences Lead, IPsoft, discusses how COVID-19 is driving AI adoption across the healthcare industry.
Why COVID-19 is a concern for people with diabetes
Prof. Andrew Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President of the International Diabetes Federation, highlights why COVID-19 is a particular concern for people living with diabetes.
COVID-19 higher among minority and socioeconomically disadvantaged children
A new study led by Children's National Hospital researchers shows that minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection.
How COVID-19 will reshape supply chains across the economy
Philip Ashton, CEO of 7bridges, discusses how COVID-19 will reshape supply chains across the economy.
Heart disease: The collateral damage of COVID-19
Professor Lina Badimon and Elisabetta Zanon from the European Society of Cardiology provide their thoughts on understanding and addressing the impact of COVID-19 on heart disease.
The European Green Deal amid COVID-19
President of the Sustainable Development Observatory of the European Economic and Social Committee, Peter Schmidt tells us what we need to know about the European Green Deal amid COVID-19.
U.S. healthcare workers struggling with mental health as a result of COVID-19
A new study highlights the mental health struggles faced by healthcare workers in the United States during the COVID-19 pandemic.
The negative impacts of environmental pollutants on COVID-19 health outcomes
Lauren Matelski, Peter Andrew and Pamela J. Lein discuss how environmental pollutants increase individual susceptibility to COVID-19.
Data protection implications of COVID-19 preventive measures
Member firms of Ius Laboris, give a view from Belgium, France and Germany on the data protection implications of the preventive measures in place to stop the spread of COVID-19.
21 drugs that could help to treat COVID-19
A study recently identified 21 existing drugs that could improve the effect of remdesivir.
How data virtualisation can aid public/private sectors during, and after, COVID-19
Alberto Pan, Chief Technical Officer, Denodo, explores the role that data integration is currently playing in the global pandemic by enabling response teams and governments to gain the upper hand and start planning for a future post COVID-19.
Healthcare systems must uncover data blind spots to drive change post-COVID-19
Dr Anas Nader, CEO at Patchwork Health explains why healthcare providers must make greater efforts to gather, analyse and act upon data blind spots to drive change post-COVID-19.
New endoscopic device to protect healthcare workers from COVID-19
A team of researchers have developed a new device to provide added protection for healthcare workers against COVID-19 during endoscopic procedures.
The challenges of COVID-19 human infection trials
Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.